Relative Dose Intensity and Pathologic Response Rates in Patients With Breast Cancer and With and Without HIV Who Received Neoadjuvant Chemotherapy

Patients who are HIV-positive and have breast cancer have worse overall survival (OS) compared with patients who are HIV-negative. Pathologic complete response (pCR) and relative dose intensity (RDI) of chemotherapy are associated with survival. We assessed whether pCR and RDI rates were lower for p...

Descripción completa

Detalles Bibliográficos
Autores principales: Martei, Yehoda M., Narasimhamurthy, Mohan, Setlhako, Dipho I., Ayane, Gezahen, Ralefala, Tlotlo, Chiyapo, Sebathu, Gross, Robert, Shulman, Lawrence N., Grover, Surbhi, DeMichele, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173574/
https://www.ncbi.nlm.nih.gov/pubmed/35584347
http://dx.doi.org/10.1200/GO.22.00016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173574/
https://www.ncbi.nlm.nih.gov/pubmed/35584347
http://dx.doi.org/10.1200/GO.22.00016

Ejemplares similares